Vaccine-maker stocks fall after RFK Jr nomination
Pfizer and Moderna shed on Wall Street after reports the vaccine sceptic will be heading up the US health department.
Shares of vaccine-makers fell after reports Donald Trump is expected to nominate vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Shares of Moderna and Pfizer dropped almost immediately after the initial report by Politico, then rebounded slightly. As of Thursday’s market close, Moderna’s stock fell 5.6 per cent and Pfizer was down 2.6 per cent.
“We’re not going to take vaccines away from anybody,” Kennedy said in an interview following Trump’s victory.
Kennedy has promised sweeping changes to food and drug regulation and government-funded scientific research, in recent days saying the Food and Drug Administration’s entire nutrition department needed to be eliminated and warning the agency’s employees to “pack your bags”.
He has also pledged to advise against fluoride in drinking water — a stance which puts him at odds with public health officials.